116 related articles for article (PubMed ID: 24005033)
1. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma.
Alholle A; Brini AT; Gharanei S; Vaiyapuri S; Arrigoni E; Dallol A; Gentle D; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
Epigenetics; 2013 Nov; 8(11):1198-204. PubMed ID: 24005033
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma.
Nestheide S; Bridge JA; Barnes M; Frayer R; Sumegi J
Pediatr Blood Cancer; 2013 Sep; 60(9):1437-46. PubMed ID: 23508900
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.
Huertas-Martínez J; Court F; Rello-Varona S; Herrero-Martín D; Almacellas-Rabaiget O; Sáinz-Jaspeado M; Garcia-Monclús S; Lagares-Tena L; Buj R; Hontecillas-Prieto L; Sastre A; Azorin D; Sanjuan X; López-Alemany R; Moran S; Roma J; Gallego S; Mora J; García Del Muro X; Giangrande PH; Peinado MA; Alonso J; de Alava E; Monk D; Esteller M; Tirado OM
Cancer Lett; 2017 Feb; 386():196-207. PubMed ID: 27894957
[TBL] [Abstract][Full Text] [Related]
4. Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Ryland KE; Hawkins AG; Weisenberger DJ; Punj V; Borinstein SC; Laird PW; Martens JR; Lawlor ER
Mol Cancer Res; 2016 Jan; 14(1):26-34. PubMed ID: 26573141
[TBL] [Abstract][Full Text] [Related]
5. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
Gharanei S; Brini AT; Vaiyapuri S; Alholle A; Dallol A; Arrigoni E; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
Epigenetics; 2013 Sep; 8(9):893-8. PubMed ID: 23887284
[TBL] [Abstract][Full Text] [Related]
6. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
Avigad S; Shukla S; Naumov I; Cohen IJ; Ash S; Meller I; Kollender Y; Issakov J; Yaniv I
Pediatr Blood Cancer; 2009 Dec; 53(6):1023-8. PubMed ID: 19637319
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
9. Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1.
Hotfilder M; Mallela N; Seggewiß J; Dirksen U; Korsching E
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563222
[TBL] [Abstract][Full Text] [Related]
10. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
11. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
12. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.
Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F; Hogendoorn PC; Picci P; Knuutila S; Dirksen U; Debiec-Rychter M; Schaefer KL; de Álava E
Oncogene; 2012 Mar; 31(10):1287-98. PubMed ID: 21822310
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
Asano N; Takeshima H; Yamashita S; Takamatsu H; Hattori N; Kubo T; Yoshida A; Kobayashi E; Nakayama R; Matsumoto M; Nakamura M; Ichikawa H; Kawai A; Kondo T; Ushijima T
Sci Rep; 2019 Dec; 9(1):20360. PubMed ID: 31889115
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma.
Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ
Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734
[TBL] [Abstract][Full Text] [Related]
15. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of INK4A deletion in Ewing sarcoma.
Wei G; Antonescu CR; de Alava E; Leung D; Huvos AG; Meyers PA; Healey JH; Ladanyi M
Cancer; 2000 Aug; 89(4):793-9. PubMed ID: 10951342
[TBL] [Abstract][Full Text] [Related]
17. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.
Kovar H
Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Yin X; Sun J; Zhang H; Wang S
Mol Med Rep; 2018 Nov; 18(5):4229-4238. PubMed ID: 30221671
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
[TBL] [Abstract][Full Text] [Related]
20. Novel splice variants of CXCR4 identified by transcriptome sequencing.
Sand LG; Jochemsen AG; Beletkaia E; Schmidt T; Hogendoorn PC; Szuhai K
Biochem Biophys Res Commun; 2015 Oct; 466(1):89-94. PubMed ID: 26321665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]